4//SEC Filing
Cui Jingrong Jean 4
Accession 0001209191-20-035621
CIK 0001595893other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:26 PM ET
Size
14.9 KB
Accession
0001209191-20-035621
Insider Transaction Report
Form 4
Cui Jingrong Jean
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2020-06-09$63.80/sh−412$26,286→ 549,471 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$64.82/sh−1,688$109,416→ 547,783 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$66.60/sh−2,585$172,161→ 540,683 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$65.80/sh−4,515$297,087→ 543,268 total(indirect: By Spouse) - Sale
Common Stock
2020-06-09$67.48/sh−300$20,244→ 540,383 total(indirect: By Spouse)
Holdings
- 1,001,298
Common Stock
- 300,000(indirect: By The Jean Cui 2020 GRAT)
Common Stock
Footnotes (6)
- [F1]Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
- [F2]The weighted average sale price for the transaction reported was $63.80, and the range of prices were between $63.25 and $64.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $64.82, and the range of prices were between $64.26 and $65.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The weighted average sale price for the transaction reported was $65.80, and the range of prices were between $65.26 and $66.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]The weighted average sale price for the transaction reported was $66.60, and the range of prices were between $66.27 and $67.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F6]The weighted average sale price for the transaction reported was $67.48, and the range of prices were between $67.34 and $67.915. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001772259
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:26 PM ET
- Size
- 14.9 KB